In SLE patients, BM abnormalities are not rare and reported features include hypocellularity, necrotic alterations, reduced CD34+ HSC frequency as well as elevation of markers like CD95, CD123 and CD166 [21,22,23]. Here, ALCAM is linked to systemic lupus erythematosus.